(2017). Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study. BMJ.
Chicago Stili Alıntı"Low LDL Cholesterol, PCSK9 and HMGCR Genetic Variation, and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomisation Study." BMJ 2017.
MLA Alıntı"Low LDL Cholesterol, PCSK9 and HMGCR Genetic Variation, and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomisation Study." BMJ 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..